Borregaard Synthesis manufacturers fine chemicals for the global pharmaceutical market, with streamlined core capabilities serving targeted applications including advanced intermediates, x-ray contrast media (XRCM) intermediates, active pharmaceutical ingredients (APIs), and specialty excipients.
The business has engaged in a continual process of restructuring over the past decade, consistent with streamlining to meet market needs. Borregaard Synthesis is focused on its core capabilities and positioned to be highly competitive in meeting the demands of the modern pharmaceutical market.
|